Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic Impairment

NCT03160014 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: SHR3824

Sponsor

Jiangsu HengRui Medicine Co., Ltd.